Fatal – Talk Bio

Actionable Insights Powered by AI

Pfizer Withdraws Sickle Cell Disease Treatment Oxbryta Globally Due to Safety Concerns

Pfizer, Oxbryta, sickle cell disease, global market withdrawal, safety concerns, clinical trials, vaso-occlusive crises, fatal events